HEPION PHARMACEUTICALS
Live / Registered — Registered (as of 08 Jun 2021)
What this means for you
Registered since 08 Jun 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 08 Jun 2027, and its filing window is open now).
Record
- Serial number
- 90062384
- Registration number
- 6382180
- Mark type
- Word mark
- Filed
- 20 Jul 2020
- Published for opposition
- 17 Nov 2020
- Registered
- 08 Jun 2021
- Next maintenance filing
- §8 declaration of use, due by 08 Jun 2027 (grace period to 08 Dec 2027)
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of diseases of the liver, diseases of the lungs and pulmonary system, infectious diseases, and fibrosis; anti-virals and anti-inflammatories
Owner
- Hepion Pharmaceuticals, Inc., Edison, NJ, US
- Hepion Pharmaceuticals, Inc., Edison, NJ, US
- Hepion Pharmaceuticals, Inc., Edison, NJ, US
Prosecution history
- 08 Jun 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 01 May 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Mar 2021 — USE AMENDMENT FILED
- 16 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 12 Jan 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Nov 2020 — PUBLISHED FOR OPPOSITION
- 28 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED